A heating and freezing process known as dual thermal ablation can kill pancreatic cancer cells, according to new research from Binghamton University, State University at New York.
The collaborative study, conducted by researchers from academia and industry and funded by grants from the National Cancer Institute, used pancreatic cancer cells to investigate the effect of heating and freezing on cell death. The research was conducted by Robert Van Buskirk and John Baust, professors of biological sciences and directors at Binghamton University’s Institute of Biomedical Technology, and Kenneth Baumann, a graduate student studying biology.
“How do we solve the problem of pancreatic cancer when it comes to trying to get rid of the tumor, when chemo and radiation just simply doesn’t work?” said Van Buskirk. “The whole idea is, can one come up with a different surgical intervention that’s less invasive and more effective?
“In order to figure that out, you can commercially obtain pancreatic cancer cells and grow them on specialized plasticware,” Van Buskirk said. “The basic question is, are both freezing and heat in combination more effective than freezing or heat alone? If you freeze pancreatic cancer cells like you do in cryoablation, a lot of them die, but some will survive and regrow. If you heat them, they’ll die, but again some will come back. But with dual-thermal ablation, for reasons that we do not yet understand, more die and don’t come back. In fact, over time, cells that survive the initial insult continue to die.”
“What we’ve observed is that we are able to achieve complete cell death using a combination of heating and then freezing at temperatures that alone would not be lethal to kill pancreatic cancer cells,” said Baumann.
Researchers heated and froze cancer cells and looked at the effect, using various technologies to determine the level of cell death, on regrowth as well as which cell stress pathways were activated.
“Using a variety of assays, we are able to determine the initial level of cell death as well as to what extent the surviving population is able to regrow,” Baumann said. “We were also able to determine the specific paths of cell death activated as a result of the dual thermal exposure.”
“When cells are disturbed—which means they are frozen or they see heat—various cell stress pathways are activated,” said Van Buskirk. “The interesting thing about cells, especially cancer cells, is that they will activate pathways to protect themselves. The objective of this line of molecular-based research is to find out which stress pathways are activated in pancreatic cancer cells so that we can better understand why dual-thermal ablation appears to be more effective.”
“Current studies are focused on elucidating which stress pathways specifically cause these cells to die or what is keeping them alive. That way, we can optimize this treatment to be as effective as possible against pancreatic cancer,” Baumann said.
According to Van Buskirk, modulating these stress pathways is the key to making the heating and freezing ablation process more effective. This could lead to the development of a new way to remove cancerous pancreatic tumors.
In addition to the cell molecular research, several members of the study team are working on developing new catheter technologies to deliver this ablative therapy to patients. “If a very thin catheter can be developed to target the tumor, and if we understand how pancreatic cancer responds to ablation at the molecular level, then we may be able to develop a new therapy to approach something that has been completely unapproachable, the targeted killing of a tumor in a very difficult place: the pancreas,” said Van Buskirk.
The Latest on: Pancreatic cancer
- University PR misleads with claim that preliminary blood test detects early pancreatic cancer on September 19, 2018 at 8:01 am
The headline of this news release — ‘New blood test detects early stage pancreatic cancer’ — is misleading since the study results are quite preliminary, and the blood test was given to those already ... […]
- Dana-Farber, MIT target pancreatic cancer on September 19, 2018 at 5:48 am
Two new pancreatic cancer research laboratories opening at MIT and the Dana-Farber Cancer Institute are giving researchers and patients renewed hope in fighting a disease that claims thousands of live... […]
- Michigan Opera Theatre Founder David DiChiera Passes Away of Pancreatic Cancer on September 19, 2018 at 3:00 am
Dr. David DiChiera, Founder and long-time General Director of Michigan Opera Theatre (MOT), died today at his home in Detroit with his family by his side. He was 83 years old and had been diagnosed wi... […]
- New Blood Test That Detects Pancreatic Cancer Early Could Be Available In Two Years on September 19, 2018 at 2:04 am
A new blood test that can detect pancreatic cancer with 96% accuracy at stages one or two could be made available to British patients within a few years. Pancreatic cancer is one of the deadliest form... […]
- Michigan Opera Theatre Founder David DiChiera Succumbs to Pancreatic Cancer on September 18, 2018 at 9:54 pm
DiChiera was a visionary and a beloved figure throughout the international opera world, but it was in Detroit and at MOT that he made his mark. He was known for his love of the city and for championin... […]
- Paramus fundraiser aims to end pancreatic cancer, one of the deadliest forms of disease on September 18, 2018 at 2:51 am
Paramus fundraiser aims to end pancreatic cancer, one of the deadliest forms of disease Jeanne Weber, a borough councilwoman, started the walk 12 years ago after she lost her husband, Ron, to the dise... […]
- Pancreatic Cancer Action Network Announces 2019 Grants Program To Fund Innovative Scientists on September 17, 2018 at 5:47 am
"The need for continued research funding, both public and private, is urgent, as pancreatic cancer patients have the lowest five-year survival rate of any major cancer at just 9 percent," said Lynn Ma... […]
- New blood test detects early stage pancreatic cancer on September 17, 2018 at 5:35 am
Axial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domain Pancreatic cancer is currently very difficult to detect while it is still resectable. […]
- Researchers develop new blood test to detect early stage pancreatic cancer on September 17, 2018 at 4:06 am
Pancreatic cancer is currently very difficult to detect while it is still resectable. A new blood test developed by researchers at Lund University in Sweden, Herlev Hospital, Knight Cancer Center and ... […]
- Wage hope at pancreatic cancer fundraiser on September 16, 2018 at 3:29 pm
Christina's fourth annual Pancreatic Cancer Fundraiser dinner to wage hope to help find a cure will be held Sept. 29 at the Veterans Memorial Building, 125 E. F St. Doors will open at 5:45 p.m. and a ... […]
via Google News and Bing News